COMMUNIQUÉS West-GlobeNewswire

Zomedica to Present at Raymond James Life Sciences and MedTech Conference
12/06/2019
ANN ARBOR, Mich., June 12, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the [...]
iCAD Announces Proposed Public Offering of Common Stock
12/06/2019
NASHUA, N.H., June 12, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it has commenced [...]
Cerecor Appoints Keith Schmidt to its Board of Directors
12/06/2019
ROCKVILLE, Md., June 12, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
Nuvectra® to Participate in Two Upcoming Investor Conferences
12/06/2019
PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming [...]
Cytokinetics to Present at the JMP Securities Life Sciences Conference
12/06/2019
SOUTH SAN FRANCISCO, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate [...]
Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin
12/06/2019
OCALA, Fla., June 12, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. announced today that the first patient has been treated in the Phase 2 recurrent ovarian cancer program at the University [...]
AB Science announces the positive recommendation of IDMC following the interim analysis of study in the first-line treatment of pancreatic cancer
12/06/2019
Paris, June 12, 2019, 7.45pm Interim results for confirmatory masitinib study in pancreatic cancer with pain IDMC recommends to continue study. Chance of success above 80% in patients with locally advanced tumors if [...]
AB Science annonce la recommandation positive de l'IDMC suite à l’analyse intérimaire dans le cancer du pancréas en première ligne de traitement
12/06/2019
Paris, 12 juin 2019, 19h45 Résultats de l’analyse intérimaire dans l’étude confirmatoire du masitinib dans le cancer du pancréas avec douleur L’IDMC recommande la poursuite de l’étude. Probabilité de succès supérieure à [...]
Response Ortho Celebrates 15 Years of Success and Is Only Getting Started
12/06/2019
Pioneer of Web-based Pre-Op Planning Software and ExFix Technologies Makes Big Plans for Future WARSAW, Ind., June 12, 2019 (GLOBE NEWSWIRE) -- Founded in 2004, Response Ortho (RO) is celebrating 15 years of business – [...]
CTD Holdings Submits Application for Listing on NASDAQ
12/06/2019
ALACHUA, FL, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with [...]
Adynxx Stock to Move to OTC Market Following Receipt of Nasdaq Delisting Notice
12/06/2019
Company on Track with All Business Operations and Clinical Development Plans for Brivoligide While Pursuing Options to Comply with Nasdaq’s Initial Listing Requirements SAN FRANCISCO, June 12, 2019 (GLOBE NEWSWIRE) -- [...]
Bone Therapeutics announces results of Annual General Meeting
12/06/2019
Press Release Significantly strengthened its Board of Directors with appointment of Gloria Matthews as Independent Director Shareholders also approved all other resolutions Gosselies, Belgium, 12 June 2019, 6pm CEST – [...]
Bone Therapeutics annonce les résultats de son Assemblée Générale
12/06/2019
Communiqué de presse Renforcement du Conseil d‘Administration avec la nomination de Gloria Matthews en qualité d’administratrice indépendante Approbation de l’ensemble des autres résolutions Gosselies, Belgique, le 12 [...]
SuperSonic Imagine will present its new Aixplorer MACH 30 ultrasound and its new breast imaging solutions at the SIFEM conference
12/06/2019
In Lille from 13 to 15 June 2019 AIX-EN-PROVENCE, France, June 12, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible), a company that specialises in ultrasound medical imaging ( [...]
CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Offering of Topical Products
12/06/2019
PlusCBD™ Oil Roll-On Launch at 945 Kroger Stores in 17 U.S. States LAS VEGAS, June 12, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier [...]
Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate
12/06/2019
Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate Based on DSMB clearance, two lead dosage levels have been selected for ongoing Phase 2 clinical development Saint-Herblain ( [...]
Valneva annonce le succès de la première étape de Phase 2 pour son vaccin contre la maladie de Lyme
12/06/2019
Valneva annonce le succès de la première étape de Phase 2 pour son vaccin contre la maladie de Lyme Sur avis du DSMB, deux dosages du vaccin ont été sélectionnés pour la suite de l’étude clinique de Phase 2 actuellement [...]
Innate Pharma announces intention to conduct a registered offering in the United States
12/06/2019
INNATE PHARMA ANNOUNCES INTENTION TO CONDUCT A REGISTERED OFFERING IN THE UNITED STATES Marseille, France, Wednesday, June 12th, 2019, 5:45 PM CEST Innate Pharma, S.A. (Euronext Paris: IPH) today announced that it plans [...]
Innate Pharma annonce son intention de procéder à une offre au public aux États-Unis
12/06/2019
INNATE PHARMA ANNONCE SON INTENTION DE PROCEDER A UNE OFFRE AU PUBLIC AUX ETATS-UNIS Marseille, France, Mercredi 12 juin 2019, 5h45 PM CEST Innate Pharma SA (la « Société » - Euronext Paris: FR0010331421 – IPH), annonce [...]

Pages